US BANCORP \DE\ - PEAR THERAPEUTICS INC ownership

PEAR THERAPEUTICS INC's ticker is and the CUSIP is 704723105. A total of 65 filers reported holding PEAR THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 1.48 and the average weighting 0.6%.

Quarter-by-quarter ownership
US BANCORP \DE\ ownership history of PEAR THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$13,999
-78.4%
54,8970.0%0.00%
Q4 2022$64,778
-42.2%
54,8970.0%0.00%
Q3 2022$112,00054,8970.00%
Other shareholders
PEAR THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Arboretum Ventures, Inc. 10,859,050$54,838,00044.55%
5AM Venture Management, LLC 18,631,771$94,090,00020.55%
TB Alternative Assets Ltd. 2,071,865$10,463,0003.59%
Palantir Technologies Inc. 1,000,000$5,050,0002.06%
SB Global Advisers Ltd 12,100,078$61,105,0001.92%
EDBI Pte Ltd 427,070$2,157,0001.44%
Temasek Holdings (Private) Ltd 26,803,573$135,358,0440.57%
Blue Water Life Science Advisors, LP 194,686$983,0000.47%
Sarissa Capital Management LP 500,356$2,527,0000.24%
Perceptive Advisors 926,232$4,677,0000.09%
View complete list of PEAR THERAPEUTICS INC shareholders